Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
doi: 10.3892/IJMM.2025.5515 Summary Keywords glucagon-like peptide-1, type 2 diabetes, endothelial function, obesity, metabolic syndrome Citation Hammad BF, Zafar N, Ullah M, Faisal SJ, Iftikhar F, Waheed H, Muzaffar MW, Ahmed K, Ashraf F, Zahid K, Akhtar M and Mahmmoud Fadelallah Eljack M (2025) Exploring the multifaceted roles of GLP-1 receptor agonists
EC demonstrates relatively low and variable oral bioavailability due to rapid phase II conjugation in the small intestine and liver, coupled with extensive microbial degradation in the colon ( Moreover, considerable interindividual variability in EC metabolism exists, predominantly driven by differences in gut microbiota composition and host enzymatic profiles ( To bridge these critical knowledge gaps, this review systematically explores the anti-inflammatory mechanisms of EC, emphasizing the interplay between its structural properties, metabolic fate, and the bioactivities of its microbial metabolites
The Nrf2/GCH1/BH4 axis ameliorates radiation-induced skin injury by modulating the ROS cascade
A human dose of 200mcg (approximately 2.53mcg/kg for a 70kg adult) does not directly translate to 2.5mcg/kg in a ratpreclinical models use 50100 higher per-kilogram doses to produce comparable GH secretion peaks
Everyones body is different, so the timeline can vary
Any references to skin, collagen, extracellular matrix, or oxidative-stress pathways are provided only for research context and do not imply cosmetic or clinical use
